These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Neuroleptic malignant syndrome: a case report. Fekadu A, Wakwoya A. Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317 [Abstract] [Full Text] [Related]
50. Successful treatment of a complicated case of neuroleptic malignant syndrome. Lappa A, Podestà M, Capelli O, Castagna A, Di Placido G, Alampi D, Semeraro F. Intensive Care Med; 2002 Jul; 28(7):976-7. PubMed ID: 12122539 [Abstract] [Full Text] [Related]
51. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases. Goulon M, de Rohan-Chabot P, Elkharrat D, Gajdos P, Bismuth C, Conso F. Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201 [Abstract] [Full Text] [Related]
53. [A young woman with a labile mood, hyperactivity, hyperthermia and exhaustion: symptoms of lethal catatonia]. ter Haar IM, Rutgers RJ, Egbers PH. Ned Tijdschr Geneeskd; 2006 Aug 12; 150(32):1753-5. PubMed ID: 16948232 [Abstract] [Full Text] [Related]
54. Hyperthermia and rhabdomyolysis in an adolescent treated with topiramate and olanzapine. Strawn JR, Adler CM, Strakowski SM, DelBello MP. J Child Adolesc Psychopharmacol; 2008 Feb 12; 18(1):116-8. PubMed ID: 18294095 [No Abstract] [Full Text] [Related]
58. Neuroleptic malignant syndrome. The results of a 6-month prospective study of incidence in a state psychiatric hospital. Friedman JH, Davis R, Wagner RL. Clin Neuropharmacol; 1988 Aug 12; 11(4):373-7. PubMed ID: 2905208 [No Abstract] [Full Text] [Related]